Project Number #21043 Agency/Funding Organization Alzheimer Forschung Initiative e. V. Funding Year 2022 View Full Project Details for Targeting serotonin receptors to treat Alzheimer's disease and other tauopathies Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 2. Tau c. Tau-Mediated Pathogenesis (AD and ADRD) Researcher and Organization Principal Investigator Evgeni Ponimaskin Principal Investigator Evgeni Ponimaskin Awardee Organization Hannover Medical School Contact PI Country Germany Project Detail FY Overall Cost $126,000 Funding Organization Agency/Funding Organization Alzheimer Forschung Initiative e. V. Funding Organization Country Germany Program Official l.thienpont@alzheimer-forschung.de
